India is an attractive pharmaceutical market, ranking in the top three globally in volume and the top ten in sales. While new government-financed health insurance programs are increasing coverage, access to insurance remains limited.
Direct-to-consumer promotion of prescription-only medicines in India is not permitted. Major emphasis is placed on responsible behavior and compliance with regulations and codes. All communications and marketing materials are expected to be consistent with the requirements with local laws and codes of practice.
Sign up to get the guides
Select the guides you wish to download